STEAP3 and colorectal carcinoma: STEAP3-AS1 competitively binds to YTHDF2, leading to the disassociation of YTHDF2 with STEAP3 mRNA and then preventing the m6A-mediated degradation of STEAP3 mRNA, thus activating Wnt/β-catenin signaling to support CRC progression (92).